164 related articles for article (PubMed ID: 22315013)
1. Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara.
Pagano L; Caputo M; Samà MT; Garbaccio V; Zavattaro M; Mauri MG; Prodam F; Marzullo P; Boldorini R; Valente G; Aimaretti G
Endocrine; 2012 Oct; 42(2):382-90. PubMed ID: 22315013
[TBL] [Abstract][Full Text] [Related]
2. How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?
Pagano L; Mele C; Arpaia D; Samà MT; Caputo M; Ippolito S; Peirce C; Prodam F; Valente G; Ciancia G; Aimaretti G; Biondi B
Endocrine; 2017 Apr; 56(1):129-137. PubMed ID: 27230768
[TBL] [Abstract][Full Text] [Related]
3. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
4. RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Solodyannikova OI; Kmetyuk YV; Danilenko VV; Sukach GG
Probl Radiac Med Radiobiol; 2020 Dec; 25():579-591. PubMed ID: 33361863
[TBL] [Abstract][Full Text] [Related]
5. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
[TBL] [Abstract][Full Text] [Related]
6. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
Goffredo P; Roman SA; Sosa JA
Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
[TBL] [Abstract][Full Text] [Related]
7. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
[TBL] [Abstract][Full Text] [Related]
8. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
9. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
[TBL] [Abstract][Full Text] [Related]
10. Low but measurable stimulated serum thyroglobulin levels <2 µg/L frequently predict incomplete response in differentiated thyroid cancer patients.
Aldawish M; Jha N; McEwan AJ; Severin D; Ghosh S; Morrish DW
Endocr Res; 2014; 39(4):157-63. PubMed ID: 24460082
[TBL] [Abstract][Full Text] [Related]
11. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of differentiated thyroid carcinoma in children and adolescents.
Negre Busó M; García Burillo A; Simó Perdigó M; Galofré Mora P; Boronat de Ferrater M; Cuberas Borrós G; Sábado Álvarez C; Castell Conesa J
J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1431-1441. PubMed ID: 32877364
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital.
Lim II; Hochman T; Blumberg SN; Patel KN; Heller KS; Ogilvie JB
Thyroid; 2012 Mar; 22(3):269-74. PubMed ID: 22233131
[TBL] [Abstract][Full Text] [Related]
14. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
15. TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.
Yang X; Li J; Li X; Liang Z; Gao W; Liang J; Cheng S; Lin Y
J Nucl Med; 2017 Feb; 58(2):258-265. PubMed ID: 27493271
[TBL] [Abstract][Full Text] [Related]
16. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
17. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
18. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
19. Pyramidal lobe decreases endogenous TSH stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer.
Sawicka-Gutaj N; Klimowicz A; Sowinski J; Oleksa R; Gryczynska M; Wyszomirska A; Czarnywojtek A; Ruchala M
Ann Endocrinol (Paris); 2014 Jul; 75(3):141-7. PubMed ID: 24997767
[TBL] [Abstract][Full Text] [Related]
20. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
